Related Experiment Video

Updated: Jun 28, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

[Antimicrobial effects of erythromycin microspheres against Mycoplasma Pneumoniae in rats]

Tao Li1, Jing Wen, Wen-ling Jiang

  • 1Department of Pharmacy, People's Hospital of Guangdong Province, Guangzhou 510080, China.

Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University
|October 31, 2008
PubMed
Abstract

Insights

Erythromycin microspheres show significant antimicrobial activity against Mycoplasma pneumoniae in rats. This study demonstrates their therapeutic potential in treating Mycoplasma pneumoniae infections.

Area of Science:

  • Microbiology
  • Pharmacology
  • Veterinary Medicine

Context:

  • Mycoplasma pneumoniae infections pose a significant challenge in both human and animal health.
  • Developing effective antimicrobial treatments is crucial for managing these infections.
  • Erythromycin is a known antibiotic, but its delivery via microspheres warrants investigation for improved efficacy.

Purpose:

  • To assess the antimicrobial efficacy of erythromycin microspheres against Mycoplasma pneumoniae in a rat model.
  • To determine the dose-dependent therapeutic effects of erythromycin microspheres.
  • To compare the efficacy of erythromycin microspheres with erythromycin lactobionate.

Summary:

  • Erythromycin microspheres were administered intragastrically to Wistar rats infected with Mycoplasma pneumoniae at doses of 0.1, 0.5, and 1.2 g.kg(-1).d(-1) for six days.
  • Significant alleviation of infection symptoms and reduction in lung index were observed, with a clear dose-response relationship.
  • The positive control, erythromycin lactobionate, was used for comparison, and erythromycin microspheres demonstrated strong antimicrobial activity.

Impact:

  • Erythromycin microspheres represent a promising drug delivery system for treating Mycoplasma pneumoniae infections.
  • The findings support the potential use of erythromycin microspheres as a viable therapeutic option.
  • Further research may explore the clinical application of this formulation in veterinary medicine.

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...